NDC11 69625073501
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 69625-0735-01 | 69625-0735 |
| 69625-0735-1 | 69625-0735 |
| 69625-735-01 | 69625-735 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| La Roche Posay Laboratoire Dermatologique Effaclar AZ Acne Treatment | SALICYLIC ACID | COSMETIQUE ACTIVE PRODUCTION | 75e15ed6-e871-4dde-b7fc-145054626fa9 | 2025-06-12 | Warnings | 69625-735-01 69625-735 69625073501 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.